MC-Rx Listed by genesis Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
MC-Rx has been listed by the genesis ransomware group after internal files were exfiltrated in a ransomware attack, with the incident disclosed on March 31, 2026. The number of people affected remains undisclosed; individuals are advised to check whether their data may have been exposed and to take appropriate protective steps.
Inside the incident
The only confirmed public information is the March 31, 2026 listing by genesis. The group asserts that files were removed from MC-Rx systems. No statement from MC-Rx has addressed the claim, and the scale of any encryption or the duration of any unauthorized access remains undisclosed.
Who is genesis?
Genesis operates as a ransomware group that employs a double-extortion model: it encrypts systems and then lists victims on a leak site when payment demands are not met. Public records show the group has claimed responsibility for intrusions across multiple industries in recent years, typically advertising stolen files to pressure targets.
About MC-Rx
MC-Rx, previously known as MC-21 and ProCare PBM, functions as a pharmacy benefit manager. Entities in this sector process prescription claims, maintain formularies, and handle data exchanges between pharmacies, insurers, and plan sponsors. A compromise at such an organization can affect downstream services even when the precise records involved are not yet specified.
The information in question
The listing refers only to “internal files exfiltrated in ransomware attack.” No inventory of file types or record categories has been published. Pharmacy benefit managers routinely process claims data, prescriber information, and eligibility records, but whether any of those categories appear in the exfiltrated material has not been confirmed.
Why it matters
Operational records held by benefit managers can reveal patterns of medication use and business relationships. When such material is removed, affected organizations face potential regulatory scrutiny and the need to review downstream data-sharing agreements, regardless of whether the files are later published.
If your data was in this claimed breach
Public information does not yet identify specific individuals. Those concerned can take the following steps:
- Review account statements from health plans and pharmacies for unexpected activity.
- Enable multi-factor authentication on any portals that store prescription or benefits information.
- Request an explanation of benefits from their plan administrator to verify recent claims.
- Run a free exposure scan of their email address against known breach repositories to check for prior appearances of their information.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
East Texas Family Medicine Listed by genesis Ransomware GroupMirage Endoscopy Center Listed by genesis Ransomware GroupFamily Medical Associates of Raleigh Listed by genesis Ransomware GroupThe American Board of Preventive Medicine Listed by genesis Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the MC-Rx Listed by genesis Ransomware Group →
Publicly posted by genesis — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.